”死の谷”を越えて　バイオベンチャー列伝４(週刊東洋経済ｅビジネス新書No.212) Audiobook By 週刊東洋経済編集部 cover art

”死の谷”を越えて　バイオベンチャー列伝４(週刊東洋経済ｅビジネス新書No.212)

 Preview
Get this deal Try for $0.00
Offer ends April 30, 2025 at 11:59PM PT.
Prime logo Prime members: New to Audible? Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 3 months. Cancel anytime.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.

”死の谷”を越えて　バイオベンチャー列伝４(週刊東洋経済ｅビジネス新書No.212)

By: 週刊東洋経済編集部
Narrated by: 海老塚 久蔵
Get this deal Try for $0.00

$14.95/mo. after 3 months. Offer ends April 30, 2025 11:59PM PT. Cancel anytime.

$14.95/month after 30 days. Cancel anytime.

Buy for $11.59

Buy for $11.59

Confirm purchase
Pay using card ending in
Switch payment method
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
Cancel

About this listen

 開発期間が長いバイオベンチャーの成長過程の中には「死の谷」と呼ばれる期間がある。この「死の谷」を越えるための資金調達は大変な難関で、企業存続の大きな分かれ道になる。

本誌では、バイオ後続品の「ジーンテクノサイエンス」、がん細胞を溶かす薬を目指す「オンコリスバイオファーマ」、経皮吸収製剤の「メドレックス」、細胞シート培養技術の「セルシード」をリポート。そのトップから技術・開発・成長戦略を語ってもらう。

本書は投資家向けの「会社四季報オンライン」に連載した「大化け創薬ベンチャーを探せ！」に、最新情報を加筆し電子化したものです。©東洋経済新報社 (P) 2018 Audible, Inc. Nature & Ecology Outdoors & Nature Science
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about ”死の谷”を越えて　バイオベンチャー列伝４(週刊東洋経済ｅビジネス新書No.212)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available